IV Tulisokibart, IV Placebo, SC Tulisokibart, SC Placebo — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-01 in 1mo
ESTIMATED |
READOUT
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participant
Phase 3 · Ulcerative Colitis |
Merck Sharp & Dohme LLC | IV Tulisokibart, IV Placebo, SC Tulisoki |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|